Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation.

Richter K, Markmann H, Kaps P, Wolff A, Simm S, Dubinski D, Gessler F, Freiman TM, Kirschstein T, Junghanss C, Maletzki C, Schneider B

Open source

DOI: 10.1007/s10571-026-01750-6
Published: 2026 May 30
Container: Cellular and molecular neurobiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10571-026-01750-6,
  title = {Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation.},
  author = {Richter K and Markmann H and Kaps P and Wolff A and Simm S and Dubinski D and Gessler F and Freiman TM and Kirschstein T and Junghanss C and Maletzki C and Schneider B},
  year = {2026},
  journal = {Cellular and molecular neurobiology},
  doi = {10.1007/s10571-026-01750-6},
  url = {https://doi.org/10.1007/s10571-026-01750-6}
}

RIS

TY  - JOUR
TI  - Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation.
AU  - Richter K
AU  - Markmann H
AU  - Kaps P
AU  - Wolff A
AU  - Simm S
AU  - Dubinski D
AU  - Gessler F
AU  - Freiman TM
AU  - Kirschstein T
AU  - Junghanss C
AU  - Maletzki C
AU  - Schneider B
PY  - 2026
JO  - Cellular and molecular neurobiology
DO  - 10.1007/s10571-026-01750-6
UR  - https://doi.org/10.1007/s10571-026-01750-6
ER  -

APA

K, R., H, M., P, K., A, W., S, S., D, D., F, G., TM, F., T, K., C, J., C, M., & B, S. (2026). Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation.. Cellular and molecular neurobiology. https://doi.org/10.1007/s10571-026-01750-6

Source records

pubmed · retrieved 2026-11-10T18:52:33.932Z